Sky Solar Holdings to Report Second Quarter 2016 Financial Results
Sep 06, 2016 20:05 pm UTC| Business
HONG KONG, Sept. 06, 2016 -- Sky Solar Holdings, Ltd. (NASDAQ:SKYS), a leading global independent power producer that develops, owns and operates solar parks, today announced that it will release financial results for...
Sep 06, 2016 20:05 pm UTC| Business
HOPKINTON, Mass., Sept. 06, 2016 -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and...
Grace to Participate in Upcoming Investor Conferences
Sep 06, 2016 20:05 pm UTC| Business
COLUMBIA, Md., Sept. 06, 2016 -- W. R. Grace Co. (NYSE:GRA) announced today its participation in two upcoming investor conferences. On September 13, 2016, Grace will participate in the KeyBanc Capital Markets Basic...
Dave & Buster’s Entertainment, Inc. Announces Second Quarter 2016 Financial Results
Sep 06, 2016 20:05 pm UTC| Business
Achieves Net Income of $21.5 million and EPS of $0.50Affirms Total Revenues, Net Income, and Adjusted EBITDA Guidance for Fiscal 2016 DALLAS, Sept. 06, 2016 -- Dave Buster's Entertainment, Inc., (NASDAQ:PLAY), (“Dave...
Five Prime Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
Sep 06, 2016 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
CDK Global Appoints Eileen Martinson and Steve Schuckenbrock to Its Board of Directors
Sep 06, 2016 20:05 pm UTC| Business
HOFFMAN ESTATES, Ill., Sept. 06, 2016 -- CDK Global, Inc. (Nasdaq:CDK) announced today that its board of directors has appointed two new highly qualified independent directors, Eileen J. Martinson and Stephen F....
Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
Sep 06, 2016 20:05 pm UTC| Business
DUBLIN, Ireland, Sept. 06, 2016 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel protein immunotherapies, today...